Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies (original) (raw)

References

  1. Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS (1989) Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol 70: 615–624
    Google Scholar
  2. Battles JK, Dalrymple JM (1988) Genetic variation among geographic isolates of Rift valley fever virus. Am J Trop Med Hyg 39: 617–631
    Google Scholar
  3. Besselaar TG, Blackburn NK (1988) Antigenic analysis of West Nile virus strains using monoclonal antibodies. Arch Virol 99: 75–88
    Google Scholar
  4. Bishop DHL, Calisher CH, Casals J, Chumakov MP, Gaidamovich SY, Hannoun C, Lvov DK, Marshall ID, Oker-Blom NM, Petterson RF, Porterfield JS, Russell PK, Shope RE, Westaway EG (1980) Bunyaviridae. Intervirology 14: 125–143
    Google Scholar
  5. Blackburn NK, Swanepoel R (1980) An investigation of flavivirus infections of cattle in Zimbabwe Rhodesia with particular reference to Wesselsbron virus. J Hyg (Camb) 85: 1–33
    Google Scholar
  6. Boere WAM, Harmsen T, Vinjè J, Benaissa-Trouw BJ, Kraaijeveld C, Snippe H (1984) Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. J Virol 52: 575–582
    Google Scholar
  7. Boere WAM, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H (1985) Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus. J Virol 54: 546–551
    Google Scholar
  8. Clarke DH, Casals J (1958) Techniques for haemagglutination and haemagglutination inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7: 561–573
    Google Scholar
  9. Collett MS, Purchio AF, Keegan K, Frazier S, Hays W, Anderson DK, Parker MD, Schmaljohn C, Schmidt J, Dalrymple JM (1985) Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus. Virology 144: 228–245
    Google Scholar
  10. Collett MS, Keegan K, Hu SL, Sridhar P, Purchio AF, Ennis WH, Dalrymple JM (1987) Protective subunit immunogens to Rift Valley fever virus from bacteria and recombinant vaccinia virus. In: Mahy BWJ, Kolakofsky D (eds) The biology of negative strand viruses. Elsevier, Amsterdam, pp 321–329
    Google Scholar
  11. Dalrymple JM, Hasty SE, Kakach LT, Collett MS (1989) Mapping protective determinants of Rift Valley fever virus using recombinant vaccinia viruses. In: Lerner RA, Ginsberg H, Chanock R, Brown F (eds) Vaccines '89. Cold Spring Harbor Laboratory, New York, pp 371–375
    Google Scholar
  12. Heinz FX, Mandl C, Berger R, Tuma W, Kunz C (1984) Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein. Virology 133: 25–34
    Google Scholar
  13. Henning D, Nielsen K (1987) Peroxidase-labelled monoclonal antibodies for use in enzyme immunoassay. J Immunoassay 8: 297–307
    Google Scholar
  14. Keegan K, Collett MS (1986) Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus. J Virol 58: 263–270
    Google Scholar
  15. Kingsford L (1984) Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein. Virology 136: 265–273
    Google Scholar
  16. Kingsford L, Ishizawa LD, Hill DW (1983) Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus. Virology 129: 443–455
    Google Scholar
  17. Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH (1979) Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans Roy Soc Trop Med Hyg 73: 630–633
    Google Scholar
  18. Lubeck MD, Gerhard W (1981) Topological mapping of antigenic sites on the influenza A/PR/8/34 virus haemagglutinin using monoclonal antibodies. Virology 113: 64–72
    Google Scholar
  19. Lubeck MD, Gerhard W (1982) Conformational changes at topologically distinct antigenic sites on the influenza A/Pr/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. Virology 118: 1–7
    Google Scholar
  20. Lussenhop NO, Goertz R, Wakube-Bunoti M, Gehrz R, Kari B (1988) Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies. Virology 164: 362–372
    Google Scholar
  21. Meegan JM, Digoutte JP, Peters CJ, Shope RE (1983) Monoclonal antibodies to identify Zinga virus as Rift Valley fever virus. Lancet i: 641
    Google Scholar
  22. Pifat DY, Osterling MC, Smith JF (1988) Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies. Virology 167: 442–450
    Google Scholar
  23. Rice RM, Erlick BJ, Rosato RR, Eddy GA, Mohanty SB (1980) Biochemical characterization of Rift Valley fever virus. Virology 105: 256–260
    Google Scholar
  24. Robeson G, El Said LH, Brandt W, Dalrymple J, Bishop DHL (1979) Biochemical studies on the phlebotomus fever group viruses (Bunyaviridae family). J Virol 30: 339–350
    Google Scholar
  25. Roehrig JT, Day JW, Kinney RM (1982) Antigenic analysis of the surface glycoproteins of a Venezuelen equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 118: 269–278
    Google Scholar
  26. Roehrig JT (1986) The use of monoclonal antibodies in studies of the structural proteins of Togaviruses and Flaviviruses. In: Schlesinger S, Schlesinger MJ (eds) The Togaviridae and Flaviviridae. Plenum, New York, pp 265–272
    Google Scholar
  27. Saluzzo JF, Smith JF (1990) Use of reassortment viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8: 369–375
    Google Scholar
  28. Schmaljohn AL, Johnson ED, Dalrymple JM, Cole GA (1982) Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297: 70–72
    Google Scholar
  29. Schmaljohn CS, Parker MD, Ennis WH, Dalrymple JM, Collett MS, Suzich JA, Schmaljohn AL (1989) Baculovirus expression of the M segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology 170: 184–192
    Google Scholar
  30. Shope RE, Peters CJ, Davies FG (1982) The spread of Rift Valley fever and approaches to its control. Bull WHO 60: 299–304
    Google Scholar
  31. Smith JF, Brown DT (1977) Envelopment of Sindbis virus: synthesis and organization of proteins in cells infected with wild type and maturation-defective mutants. J Virol 22: 662–678
    Google Scholar
  32. Spiegelberg HL (1974) Biological activities of immunoglobulins of different classes and subclasses. In: Dixon FX, Kunkel HG (eds) Advances in immunology, vol 19. Academic Press, New York, pp 259–294
    Google Scholar
  33. Stanley J, Cooper SJ, Griffin DE (1986) Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol 58: 107–115
    Google Scholar
  34. Stone MR, Nowinski RC (1980) Topological mapping of murine leukemia virus proteins by competition binding assays with monoclonal antibodies. Virology 100: 370–381
    Google Scholar
  35. Swanepoel R, Struthers JK, Erasmus MJ, Shepherd SP, McGillivray GM (1986) Comparison of techniques for demonstrating antibodies to Rift Valley fever virus. J Hyg (Camb) 97: 317–329
    Google Scholar
  36. Van Velden DJJ, Meyer JD, Olivier J, Gear JHS, McIntosh B (1977) Rift Valley fever affecting humans in South Africa. A clinico-pathological study. S A Med J 51: 867–871
    Google Scholar

Download references